Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 21

1.

HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody-positive first-degree relatives of type 1 diabetic patients.

Mbunwe E, Van der Auwera BJ, Vermeulen I, Demeester S, Van Dalem A, Balti EV, Van Aken S, Derdelinckx L, Dorchy H, De Schepper J, van Schravendijk C, Wenzlau JM, Hutton JC, Pipeleers D, Weets I, Gorus FK; Belgian Diabetes Registry.

Diabetes. 2013 Apr;62(4):1345-50. doi: 10.2337/db12-0747. Epub 2012 Nov 16.

2.

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Vandemeulebroucke E, Keymeulen B, Decochez K, Weets I, De Block C, Féry F, Van de Velde U, Vermeulen I, De Pauw P, Mathieu C, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2010 Jan;53(1):36-44. doi: 10.1007/s00125-009-1569-3. Epub 2009 Nov 7.

PMID:
19898832
3.

Interstitial radiation therapy for early-stage nasal vestibule cancer: a continuing quest for optimal tumor control and cosmesis.

Levendag PC, Nijdam WM, van Moolenburgh SE, Tan L, Noever I, van Rooy P, Mureau MA, Jansen PP, Munte K, Hofer SO.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):160-9. Epub 2006 Jul 12.

PMID:
16839706
4.

Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes.

Weets I, Truyen I, Verschraegen I, Van der Auwera B, De Schepper J, Dorchy H, Lebrethon MC, Van Gaal L, Van Rooy P, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2006 Jun;49(6):1158-62. Epub 2006 Mar 29.

PMID:
16570164
5.

The safety and tolerability of single intravenous doses of lubeluzole (Prosynap) in healthy volunteers.

Hantson L, Tritsmans L, Crabbé R, Gheuens J, Van Rooy P.

Int J Clin Pharmacol Ther. 1997 Nov;35(11):491-5.

PMID:
9401829
6.

Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole.

Van de Velde VJ, Van Peer AP, Heykants JJ, Woestenborghs RJ, Van Rooy P, De Beule KL, Cauwenbergh GF.

Pharmacotherapy. 1996 May-Jun;16(3):424-8.

PMID:
8726601
7.

Recurrent spontaneous abortion: histocompatibility between partners, response to immune therapy, and subsequent reproductive performance.

van Iddekinge B, Hofmeyr GJ, Bezwoda WR, Wadee AA, Van Rooy P.

Am J Reprod Immunol. 1993 Aug;30(1):37-44.

PMID:
8260022
8.

[Necrotizing fasciitis caused by Group-A beta-hemolytic streptococci].

Coremans P, Lambrecht G, van Rooy P, Delvigne C.

Ned Tijdschr Geneeskd. 1993 Jul 3;137(27):1364-5. Dutch. No abstract available.

PMID:
8350941
9.

Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.

Weber C, Beetens JR, Tegtmeier F, Van Rooy P, Vercammen E, Wouters L, De Clerck F.

Thromb Haemost. 1992 Aug 3;68(2):214-20.

PMID:
1412169
10.

The antihypertensive and cardiac hemodynamic effects of nebivolol.

DeCrée J, Van Rooy P, Geukens H, Haeverans K, Verhaegen H.

Angiology. 1992 May;43(5):369-77.

PMID:
1348916
11.

A multicentre trial of the aldose-reductase inhibitor tolrestat, in patients with symptomatic diabetic peripheral neuropathy. North European Tolrestat Study Group.

Macleod AF, Boulton AJ, Owens DR, Van Rooy P, Van Gerven JM, Macrury S, Scarpello JH, Segers O, Heller SR, Van Der Veen EA.

Diabete Metab. 1992 Jan-Feb;18(1):14-20.

PMID:
1563531
12.

R 75251, a new inhibitor of steroid biosynthesis.

Bruynseels J, De Coster R, Van Rooy P, Wouters W, Coene MC, Snoeck E, Raeymaekers A, Freyne E, Sanz G, Vanden Bussche G, et al.

Prostate. 1990;16(4):345-57.

PMID:
2164659
13.

Aromatase inhibition by R 76713: experimental and clinical pharmacology.

Wouters W, De Coster R, Tuman RW, Bowden CR, Bruynseels J, Vanderpas H, Van Rooy P, Amery WK, Janssen PA.

J Steroid Biochem. 1989;34(1-6):427-30.

PMID:
2696850
14.

The clinical pharmacokinetics of itraconazole: an overview.

Heykants J, Van Peer A, Van de Velde V, Van Rooy P, Meuldermans W, Lavrijsen K, Woestenborghs R, Van Cutsem J, Cauwenbergh G.

Mycoses. 1989;32 Suppl 1:67-87. Review.

PMID:
2561187
15.

Pharmacokinetic profile of orally administered itraconazole in human skin.

Cauwenbergh G, Degreef H, Heykants J, Woestenborghs R, Van Rooy P, Haeverans K.

J Am Acad Dermatol. 1988 Feb;18(2 Pt 1):263-8.

PMID:
2831254
16.

Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.

De Leeuw IH, Van Rooy P, Moeremans M, Driessens M.

Drugs. 1987;33 Suppl 2:125-30.

PMID:
3304951
17.

Serum and erythrocyte magnesium levels in type I and type II diabetics.

Vanroelen WF, Van Gaal LF, Van Rooy PE, De Leeuw IH.

Acta Diabetol Lat. 1985 Jul-Sep;22(3):185-90.

PMID:
3907234
18.

Evaluation of the effect of atenolol on the reaction time of healthy volunteers.

van Rooy P, Myburgh DP, Cilliers AJ.

Eur J Clin Pharmacol. 1985;28 Suppl:105-7.

PMID:
3902482
19.

Exertional heat stress disease.

Kains JP, De Wit S, Close P, Melot C, Nagler J, Van Rooy P.

Acta Clin Belg. 1983;38(5):315-23. No abstract available.

PMID:
6659838
20.

Bone mass in obese, goldthioglucose-treated, hyperglycaemic mice.

De Leeuw I, Van Rooy P, D'Hollander M.

Diabetologia. 1981 Feb;20(2):145-7.

PMID:
6781965
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk